CHRISMED Journal of Health and Research

CASE REPORT
Year
: 2020  |  Volume : 7  |  Issue : 1  |  Page : 68--70

Hydrocortisone and ulinastatin for miliary tuberculosis-induced septic shock and adult respiratory distress syndrome in the intensive care unit


Niraj Kumar Keyal, Manish Nakarmi 
 Department of Critical Care Medicine, B & C Medical College Teaching Hospital and Research Center, Birtamod, Jhapa, Nepal

Correspondence Address:
Niraj Kumar Keyal
Department of Critical Care Medicine, B and C Medical College Teaching Hospital and Research Centre, Birtamode, Jhapa
Nepal

Hydrocortisone and ulinastatin are anti-inflammatory agent. We hereby report the case of a patient of sputum-positive miliary pulmonary tuberculosis that developed adult respiratory distress syndrome with septic shock. The patient was treated with anti-tubercular drugs, antibiotics, inotropes, vasopressors, hydrocortisone, and ulinastatin. From this, we want to emphasize that hydrocortisone and ulinastatin can be one of the treatment options in refractory shock patient not responding to conventional treatment but requires randomized controlled trial to confirm the effectiveness of this combination.


How to cite this article:
Keyal NK, Nakarmi M. Hydrocortisone and ulinastatin for miliary tuberculosis-induced septic shock and adult respiratory distress syndrome in the intensive care unit.CHRISMED J Health Res 2020;7:68-70


How to cite this URL:
Keyal NK, Nakarmi M. Hydrocortisone and ulinastatin for miliary tuberculosis-induced septic shock and adult respiratory distress syndrome in the intensive care unit. CHRISMED J Health Res [serial online] 2020 [cited 2020 Aug 10 ];7:68-70
Available from: http://www.cjhr.org/article.asp?issn=2348-3334;year=2020;volume=7;issue=1;spage=68;epage=70;aulast=Keyal;type=0